Bangalore, India -- (SBWIRE) -- 02/14/2018 -- POC molecular diagnostics help in identification, treatment, and prevention of infectious diseases, oncology, hematology, and prenatal diseases. The demand for POC molecular diagnostic products is increasing owing to the highly developed technologies, which are used to detect and amplify deoxyribonucleic acid (DNA)/RNA.

The major factor driving the growth of this market is the increasing prevalence of pandemic diseases such as Ebola and Zika. Based on the reports by the Centers for Disease Control and Prevention (CDC) in March 2016, in Guinea and Liberia (Africa), 13 cases of Ebola were reported whereas more than 1,200 population came into contact with the virus.

Report forecast the global POC molecular diagnostics market to grow at a CAGR of 12.83% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global POC molecular diagnostics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global POC Molecular Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott
- bioMérieux
- Danaher
- F. Hoffmann-La Roche

Other prominent vendors
- Agilent Technologies
- Akonni Biosystems
- altona Diagnostics
- Atlas Genetics
- BD
- Bionano Genomics
- BJS Biotechnologies
- Certest Biotec
- Co-Diagnostics
- Devyser
- Diagenode
- DiaSorin
- ExcitePCR
- genedrive
- GenePOC
- iCubate
- Illumina
- Merck
- Meridian Bioscience
- Mesa Biotech
- Micronics
- Nanobiosym
- NeoGenomics
- Nimagen
- Novigenix
- OraSure Technologies
- Oxford Nanopore Technologies
- PathoQuest
- PierianDx
- Precision System Science
- QuantuMDx
- Randox Laboratories
- SCIENION
- Seegene
- SpeeDX
- Sysmex
- Xagenic

Market driver
- Increased companies' participation in conferences to showcase their products
- For a full, detailed list, view our report

Market challenge
- Low adoption among healthcare providers
- For a full, detailed list, view our report

Market trend
- Growing focus on next-generation products
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?

Spanning over 113 pages "Global POC Molecular Diagnostics Market 2017 - 2021" report covers Executive Summary, Scope Of The Report, Research Methodology, Introduction, Market Landscape, Market Segmentation By Application, Market Segmentation By Technology, Market Segmentation By End-User, Regional Landscape, Decision Framework, Drivers And Challenges, Market Trends, Vendor Landscape, Key Vendor Analysis, Appendix.

For more information Visit at: https://www.drugpipeline.net/technavio/global-poc-molecular-diagnostics-market-2017-2021

Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare

Related Reports;

Global Sexually Transmitted Diseases Testing Market 2018-2022 - Visit at - https://www.drugpipeline.net/technavio/global-sexually-transmitted-diseases-testing-market-2018-2022

Global Nursing Breast Pads Market 2018-2022 - Visit at - https://www.drugpipeline.net/technavio/global-nursing-breast-pads-market-2018-2022

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.